Merck jumps after CHMP backs Keytruda plus Padcev for certain bladder cancer patients, a combo with the potential to expand ...

LLY's booming GLP-1 franchise and expanding pipeline strengthen its edge over Merck despite rising competition and pricing pressure.

The TROP2 battle in first-line triple-negative breast cancer has officially kicked off. | A three-way battle among TROP2 ADCs ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Regeneron Pharmaceuticals will partner with Parabilis Medicines to discover and develop an initial five candidates ...

From April 20 to 23, 2026, the event "Where the World Meets Jingchu: Chinese and International Cultural Figures Visit Hubei" took place in Wuhan and Jingzhou. More than 10 Chinese and international ...

WhiteFiber, Inc. ("WhiteFiber" or the "Company"), a leading provider of AI infrastructure and high-performance computing solutions, today announced that it has entered into a five-year agreement to ...

RBC Capital Markets Global Healthcare Conference 2026 May 19, 2026 9:00 AM EDTCompany ParticipantsAndrew Peters - Senior ...

Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem Alvotech (NASDAQ:ALVO) Chief Strategy Officer Balaji Prasad said the biosimilar developer is preparing to resubmit three biologics ...

Regeneron Pharmaceuticals REGN has entered into a strategic research collaboration with clinical-stage biopharmaceutical company Parabilis Medicines to develop multiple therapeutic candidates. The ...

Twelve people whose stomach or colon cancers had defeated every available treatment were infused with their own immune cells, ...

Krystal Biotech is the furthest along in pursuing this approach and is ironing out details of a registrational trial for its ...